insights_auto
Why is QDEL down 3,34%?
Dive Deeperchevron_right
QDEL:NASDAQ
Quidelortho Corp
12,15 $
arrow_downward
-3,34%(-0,42) 1D
7 қаз., 12:33:25 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QDEL...
Open
12,34 $
High
12,41 $
Low
11,83 $
Mkt. cap
833,19 млн
Avg. vol.
1,51 млн
Volume
806,21 м.
52-wk high
35,58 $
52-wk low
9,92 $
EPS
-15,40 $
Beta
0,79
Shares outstanding
68,58 млн
No. of employees
6 мың
Open
12,34 $
High
12,41 $
Low
11,83 $
Mkt. cap
833,19 млн
Avg. vol.
1,51 млн
Volume
806,21 м.
52-wk high
35,58 $
52-wk low
9,92 $
EPS
-15,40 $
Beta
0,79
Shares outstanding
68,58 млн
No. of employees
6 мың
News stories
From web sources and news partners
Investing.com Canada
·
5 сағат бұрын
QuidelOrtho appoints Sanjeev Sharma as VP of investor relations By Investing.com
PR Newswire
·
5 сағат бұрын
QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations
GuruFocus
·
1 күн бұрын
QuidelOrtho (QDEL) Shares Surge 12.7% on October 5, 2026, Amid E
Profile
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
About Quidelortho Corp
CEODouglas C Bryant
Employees6,5 мың
Founded1979
HeadquartersСан-Диего, Калифорния, Америка Құрама Штаттары
SectorMedical device
Websitequidelortho.com